Zobrazeno 1 - 10
of 120
pro vyhledávání: '"M A, Pierotti"'
Autor:
Claudia Bertan, M. A. Pierotti, Fernando Ravagnani, S. Pilotti, E Leo, Federica Perrone, Sara Pizzamiglio, M Ghilotti, Susanna Zanutto, Manuela Gariboldi, Paolo Verderio
Publikováno v:
British Journal of Cancer
Background: Plasma circulating tumour-specific microRNAs (miRNAs) are promising biomarkers of tumour presence and recurrence, especially for diseases whose best chance of successful treatment requires early diagnosis and timely surgery of an already
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54a7951a5e4c9f628b1afbf22f62a244
https://doi.org/10.1038/bjc.2013.819
https://doi.org/10.1038/bjc.2013.819
Autor:
Ambra Vittoria Gualeni, Silvia Brich, M. A. Pierotti, Monica Brenca, Silvia Stacchiotti, Fabio Bozzi, Tiziana Negri, Annunziata Gloghini, Roberta Maestro, Chiara Castelli, Silvana Pilotti, Elena Conca, Rosalin Dolores Spagnuolo, Marcella Tazzari
Publikováno v:
Oncotarget, 7, 29, pp. 45015-45026
Oncotarget, 7, 45015-45026
Oncotarget
Oncotarget, 7, 45015-45026
Oncotarget
Contains fulltext : 171567.pdf (Publisher’s version ) (Open Access) Sunitinib improves the outcomes of patients with solitary fibrous tumours (SFTs). The aim of this study was to investigate and contextualise sunitinib-induced morpho-functional cha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::065c88410224936569bebb2249c7c879
https://hdl.handle.net/11368/2904174
https://hdl.handle.net/11368/2904174
Publikováno v:
Molecular and Cellular Endocrinology. 321:44-49
TRK oncogenes are observed in a consistent fraction of papillary thyroid carcinoma (PTC); they arise from the fusion of the 3' terminal sequences of the NTRK1/NGF receptor gene with 5' terminal sequences of various activating genes, such as TPM3, TPR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36dc9a1de55b5cd065b2c1a6a200e2ca
https://doi.org/10.1016/j.mce.2009.10.009
https://doi.org/10.1016/j.mce.2009.10.009
Autor:
Manuela Gariboldi, Gemma Llort, Núria Bonifaci, Javier Benítez, Ana Osorio, Miquel Angel Pujana, Xavier Solé, L De Cecco, María Josefa Mosteiro García, Ignacio Blanco, Ricardo Fernandez-Ramires, M. A. Pierotti, Trinidad Caldés, Alicia Cazorla
Publikováno v:
Dipòsit Digital de la UB
Universidad de Barcelona
Recercat. Dipósit de la Recerca de Catalunya
instname
British Journal of Cancer
Universidad de Barcelona
Recercat. Dipósit de la Recerca de Catalunya
instname
British Journal of Cancer
Background: gene expression profiling has distinguished sporadic breast tumour classes with genetic and clinical differences. Less is known about the molecular classification of familial breast tumours, which are generally considered to be less heter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae6b009542da671c538bc697c65cef92
https://doi.org/10.1038/sj.bjc.6605275
https://doi.org/10.1038/sj.bjc.6605275
Autor:
Elena Tamborini, Rossella Bertulli, Fabio Bozzi, M. A. Pierotti, Tiziana Negri, Elena Fumagalli, S. Pilotti, Alessandro Gronchi, Elena Conca, Silvia Brich
Publikováno v:
The Journal of Pathology. 217:103-112
As the range of receptor tyrosine kinase (RTK) inhibitors widens, a detailed understanding of the activating mechanisms of KIT/platelet-derived growth factor receptor (PDGFR)A and the related downstream pathways involved in the development and mainte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5b1d3a77b9a73b9dbef13b42098b486d
https://doi.org/10.1002/path.2450
https://doi.org/10.1002/path.2450
Autor:
Italia Bongarzone, L. Gorla, Giuliana Cassinelli, Mattia Cremona, Cinzia Lanzi, Giuditta Cuccuru, M. A. Pierotti, F. Miccichè, Piera Mondellini
Publikováno v:
Molecular Carcinogenesis. 48:220-231
Proteomics may help to elucidate differential signaling networks underlying the effects of compounds and to identify new therapeutic targets. Using a proteomic-multiplexed analysis of the phosphotyrosine signaling together with antibody-based validat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::af523a147445d15cdcf75e4c076e2004
https://doi.org/10.1002/mc.20474
https://doi.org/10.1002/mc.20474
Autor:
Maurizio Fermeglia, Francesca Miselli, Elena Tamborini, M. A. Pierotti, Tiziana Negri, Antonino Carbone, Paolo G. Casali, Alessandro Gronchi, Lagonigro Ms, Marco Ferrone, S. Pilotti, Sabrina Pricl, Angela Greco
Publikováno v:
Oncogene. 25:6140-6146
Imatinib-acquired resistance related to the presence of secondary point mutations has become a frequent event in gastrointestinal stromal tumors. Here, transient transfection experiments with plasmids carrying two different KIT-acquired point mutatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be217cc9b724ea6e03309dec675b180b
https://doi.org/10.1038/sj.onc.1209639
https://doi.org/10.1038/sj.onc.1209639
Autor:
G. Gallus, L. De Cecco, M. A. Pierotti, James F. Reid, Lisa M. McShane, Sara Toffanin, Cristina Ferrario, Maria Grazia Daidone, Lara Lusa, Manuela Gariboldi, Vera Cappelletti
Publikováno v:
Scopus-Elsevier
We describe a microarray experiment using the MCF-7 breast cancer cell line in two different experimental conditions for which the same number of independent pools as the number of individual samples was hybridized on Affymetrix GeneChips. Unexpected
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afc859bcb84efc78525352ade6bc75a1
https://doi.org/10.1177/172460080602100201
https://doi.org/10.1177/172460080602100201
Autor:
Laura D. Locati, Paolo Bossi, Maria Oggionni, Pasquale Quattrone, Simona Suardi, Patrizia Olmi, S. Lo Vullo, M. A. Pierotti, S. Pilotti, Luigi Mariani, Lisa Licitra, Giulio Cantù
Publikováno v:
Journal of Clinical Oncology. 22:4901-4906
Purpose To assess the role of TP53 status in predicting pathologic complete remission after primary chemotherapy in patients with ethmoidal intestinal-type adenocarcinoma (ITAC). Patients and Methods Thirty patients with ethmoidal ITAC enrolled onto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::133b8292dc575fc365d81e77da0a5b31
https://doi.org/10.1200/jco.2004.05.071
https://doi.org/10.1200/jco.2004.05.071
Autor:
V. Dal Col, M. A. Pierotti, P. Casali, S. Pilotti, E. Tamborini, LAURINI, ERIK, PRICL, SABRINA, POSOCCO, PAOLA
1. Introduction Gastrointestinal stromal tumors (GISTs) are the most common primary mesenchymal tumors of the human gastrointestinal tract, and most GISTs express constitutively activated c-Kit oncoproteins.1 Several clinical studies demonstrate that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::baca34ef72fdf2ab01d222a803ce1da2
http://hdl.handle.net/11368/2838104
http://hdl.handle.net/11368/2838104